PARP1 and neuroblastoma: Notably, FOXD3-AS1 enhances the sensitivity of chemotherapeutic drugs in neuroblastoma IMR32 and BE (2)-C cells through repression of PARP1-mediated PARylation of CTCF (41) (Figure 3).